Please login to the form below

Not currently logged in
Email:
Password:

Idis

This page shows the latest Idis news and features for those working in and with pharma, biotech and healthcare.

Quantum Pharma confirms Clinigen takeover bid

Quantum Pharma confirms Clinigen takeover bid

In 2015 it bought Idis for £225m to gain a firmer foothold in the $5bn unlicensed medicines market and in clinical trial supply.

Latest news

  • Clinigen acquires Idis for £225m Clinigen acquires Idis for £225m

    Acquisition makes them the global leader in unlicensed medicines.  . Clinigen Group is to acquire unlicensed medicines supplier Idis for £225m. ... Idis supplies unlicensed medicines predominantly on an exclusive basis through managed access programmes

  • Langland triumphs at IPA Best of Health Awards Langland triumphs at IPA Best of Health Awards

    Windsor, UK agency wins Best of Show for Idis campaign.  . Langland continued its recent awards success by picking up Best of Show for advertising to healthcare processionals at the IPA Best ... year at the IPA event, where its campaign for Idis swept

  • Langland steals the pharma show at first Lions Health Langland steals the pharma show at first Lions Health

    four silver prizes for its work for Idis.  .

  • VCCP Health takes lead at PM Society Awards VCCP Health takes lead at PM Society Awards

    There were prizes for work for AbbVie and IDIS for Langland; Becton, Dickinson &Company and AstraZeneca for Saatchi &Saatchi Health; and Teva Europe and Napp for Woolley Pau Gyro. ... Crestor for AstraZeneca by Saatchi &Saatchi Health (Joint Winner). I

  • Langland leads Global Award winners Langland leads Global Award winners

    A major integrated campaign by Langland also won the Grand Global award in the Professional Healthcare category for its work for Idis. ... And winning the Grand Global for our work for Idis is a real honour,” said Langland chief executive Philip Chin.

More from news
Approximately 1 fully matching, plus 16 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Former Quintiles president Jeff Thomis to chair Idis Former Quintiles president Jeff Thomis to chair Idis

    Idis has appointed Jeff Thomis as chairman to oversee the company's activities in creating managed access programmes for medicines. ... As specialists in the field, Idis is strongly placed to deliver highly effective solutions to our customers who

  • Suzanne Gagnon joins Idis as CMO Suzanne Gagnon joins Idis as CMO

    She was formerly chief medical officer at Icon. Idis has appointed Dr Suzanne Gagnon as its first chief medical officer. ... Dr Gagnon will lead global medical affairs at Idis, which specialises in partnering with pharma firms to support patient access

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics